Colon Cancer Clinical Trial
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Summary
This is a simple tissue collection study with no therapeutic intent. Colon tissues will be taken from standard of care procedures. Tissues will be tested for their functions, expression of immune co-signaling molecules and reactions to transduction with recombinant Listeria vectors to assess effects on expression of B7-H1 and cytokines.
Eligibility Criteria
Inclusion Criteria:
Able to provide informed consent (or have consent provided through a guardian)
No immune-modulating drug use during study or within 30 days prior to enrollment
Having colon material collected as part of standard of care
Exclusion Criteria:
Unable to provide informed consent (or have consent provided through a guardian)
Not having colon material collected as part of standard of care
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
San Antonio Texas, 78229, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.